PAPER Tagai K, Tatebe H, Matsuura S, Hong Z, Kokubo N, Matsuoka K, Endo H, Oyama A, Hirata K, Shinotoh H, Kataoka Y, Matsumoto H, Oya M, Kurose S, Takahata K, Ichihashi M, Kubota M, Seki C, Shimada H, Takado Y, Kawamura K, Zhang MR, Soeda Y, Takashima A, Higuchi M, Tokuda T
SEARCH RESULTS
270360 RESULTS
PAPER Liu E, Zhang Y, Wang JZ
Updates in Alzheimer's disease: from basic research to diagnosis and therapies.
Transl Neurodegener. 2024 Sep 4;13(1):45. PubMed.PAPER Dundee JM, Brown GC
The microglial P2Y6 receptor as a therapeutic target for neurodegenerative diseases.
Transl Neurodegener. 2024 Sep 7;13(1):47. PubMed.PAPER Zhang X, Wu H, Tang B, Guo J
Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson's disease.
Transl Neurodegener. 2024 Sep 12;13(1):48. PubMed.PAPER Sakamoto S, Riku Y, Nomura TK, Kimura A, Yamahara N, Ohuchi K, Yoshida M, Iwasaki Y, Shimohata T, Inden M, Honda R
Ultrasensitive detection of TDP-43 and amyloid-β protein aggregates using micelle-assisted seed amplification assay.
Transl Neurodegener. 2024 Oct 8;13(1):51. PubMed.PAPER Lu J, Wu K, Sha X, Lin J, Chen H, Yu Z
TRPV1 alleviates APOE4-dependent microglial antigen presentation and T cell infiltration in Alzheimer's disease.
Transl Neurodegener. 2024 Oct 29;13(1):52. PubMed.PAPER Song C, Huang W, Zhang P, Shi J, Yu T, Wang J, Hu Y, Zhao L, Zhang R, Wang G, Zhang Y, Chen H, Wang H
Critical role of ROCK1 in AD pathogenesis via controlling lysosomal biogenesis and acidification.
Transl Neurodegener. 2024 Nov 4;13(1):54. PubMed.PAPER Zhu J, Wu C, Yang L
Cellular senescence in Alzheimer's disease: from physiology to pathology.
Transl Neurodegener. 2024 Nov 20;13(1):55. PubMed.PAPER Kuang Y, Mao H, Huang X, Chen M, Dai W, Gan T, Wang J, Sun H, Lin H, Liu Q, Yang X, Xu PY
α-Synuclein seeding amplification assays for diagnosing synucleinopathies: an innovative tool in clinical implementation.
Transl Neurodegener. 2024 Nov 21;13(1):56. PubMed.PAPER Gómez de San José N, Halbgebauer S, Steinacker P, Anderl-Straub S, Abu-Rumeileh S, Barba L, Oeckl P, Bellomo G, Gaetani L, Toja A, Mravinacová S, Bergström S, Månberg A, Grassini A, Rainero I, Nilsson P, Parnetti L, Otto M
Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer's disease.
Transl Neurodegener. 2024 Nov 29;13(1):57. PubMed.PAPER McDowall S, Bagda V, Hodgetts S, Mastaglia F, Li D
Controversies and insights into PTBP1-related astrocyte-neuron transdifferentiation: neuronal regeneration strategies for Parkinson's and Alzheimer's disease.
Transl Neurodegener. 2024 Dec 3;13(1):59. PubMed.PAPER Power SK, Venkatesan S, Qu S, McLaurin J, Lambe EK
Enhanced prefrontal nicotinic signaling as evidence of active compensation in Alzheimer's disease models.
Transl Neurodegener. 2024 Dec 3;13(1):58. PubMed.PAPER Wang L, Zhang X, Yang Z, Wang B, Gong H, Zhang K, Lin Y, Sun M
Extracellular vesicles: biological mechanisms and emerging therapeutic opportunities in neurodegenerative diseases.
Transl Neurodegener. 2024 Dec 6;13(1):60. PubMed.PAPER Weiss F, Hughes L, Fu Y, Bardy C, Halliday GM, Dzamko N
Astrocytes contribute to toll-like receptor 2-mediated neurodegeneration and alpha-synuclein pathology in a human midbrain Parkinson's model.
Transl Neurodegener. 2024 Dec 16;13(1):62. PubMed.PAPER Xue YY, Zhang ZS, Lin RR, Huang HF, Zhu KQ, Chen DF, Wu ZY, Tao QQ
CD2AP deficiency aggravates Alzheimer's disease phenotypes and pathology through p38 MAPK activation.
Transl Neurodegener. 2024 Dec 19;13(1):64. PubMed. Correction.Current Filters
- TYPE: Paper x